Cass’s impact is backed by clinical research and top universities.
Palo Alto University
Study validates Tess can reliably use the PHQ-9 to allow the assessment of depressive symptoms remotely, at a large scale and low cost.
Published in Frontiers Journal 2021.
Read the paper
Universidad Adventista del Plata
Randomized Controlled Trial validates efficacy and generalizability for Tess to reduce symptoms of depression and anxiety in university students.
Under review for publication; 2019
Read the paper
Northwestern University Randomized Controlled Trial
Finds Tess to significantly reduces symptoms of depression and anxiety.
Fulmer et al. (2018) JMIR Mental Health
Read the paper
Duke University
Expanding Access to Depression Treatment in Kenya Through Automated Psychological Support
Published in JMIR Research Protocols April 2019
Read the paper
Duke University
Feasibility study setup IRB RCT for Tess to support mothers in Kenya.
Published in JMIR Mental Health; 2019
Read the paper
Washington University School of Medicine
Randomized Controlled Trial highlights effectiveness of Tess for eating disorders prevention.
Published in International Journal of Eating Disorders; 2022
Read the paper
Employee Assistance Program Association
Case studies reveal Tess’ contribution to ROI while delivering emotional support to employees.
Published in Journal of Employee Assistance; 2018
Read the paper
CABHI and Saint Elizabeth Healthcare
Study explores how Tess delivers comprehensive support across employees and patients.
Published on PubMed (2018)
Read the paper
Nemours Children’s Hospital
Feasibility study validates Tess as an adjunct to pre-diabetes and obesity program.
Published in Translational Behavioral Medicine; 2018
Read the paper
Saint Elizabeth Healthcare
Study validates Tess as a support caregivers and nurses.
Published in Nursing Leadership; 2017
Read the paper
